Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey

PURPOSE: Access to essential cancer medicines is a major determinant of childhood cancer outcomes globally. The degree to which pediatric oncologists deem medicines listed on WHO's Model List of Essential Medicines for Children (EMLc) essential is unknown, as is the extent to which such medicin...

Descripción completa

Detalles Bibliográficos
Autores principales: Denburg, Avram E., Fundytus, Adam, Khan, Muhammad Saghir, Howard, Scott C., Antillon-Klussmann, Federico, Sengar, Manju, Lombe, Dorothy, Hopman, Wilma, Jalink, Matthew, Gyawali, Bishal, Trapani, Dario, Roitberg, Felipe, De Vries, Elisabeth G. E., Moja, Lorenzo, Ilbawi, André, Sullivan, Richard, Booth, Christopher M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259119/
https://www.ncbi.nlm.nih.gov/pubmed/35749676
http://dx.doi.org/10.1200/GO.22.00034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259119/
https://www.ncbi.nlm.nih.gov/pubmed/35749676
http://dx.doi.org/10.1200/GO.22.00034

Ejemplares similares